SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.160+2.7%Jan 16 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
Another_Voice_2
To: drkaz who wrote (11281)11/6/2018 9:37:56 AM
From: donpat1 Recommendation  Read Replies (3) of 12873
 
The trigger here, of course is that first FDA approval.

Then the avalanche to many cures begins. All in NNVC? Or each virus in its own company? I figure all in NNVC to start at least, with spin offs as required.

I figure viruses are a cause of many diseases. After this instant message is posted I intend to investigate Parkinsons!! Here's a tidbit:

"In rare instances, Parkinson's disease may be caused by a viral infection"

I get the feeling that nothing is ever clear cut and simple. I prefer simple and figure complication is a cop out!! ;) I bet Parkinson's and Alzheimer's are in cahoots!!!!! And the solution is OneCide that will simultaneously cure both. SIMPLE. What I want, of course is a universal cide to obliterate all viuses - VirusCide. So simple!!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News